CERRP
The Centre for Studies and Research on RadioPharmaceuticals was created in 2007 as a result of a partnership between the University of Tours, Inserm, the Tours University Hospital - CHRU and Cyclopharma Laboratories, within the framework of the joint research unit U930 Imaging and Brain. It is financially supported by the Centre Region, the Feder, Tour(s)plus and the General Council of Indre-et-Loire.
This association of knowledge and production resources is based on the establishment of a cyclotron dedicated to fluorine 18, in the heart of the Touraine urban area.
The CERRP is involved in numerous projects at European and national level: INMIND (Imaging Neuroinflammation in Neurodegenerative Diseases), the Labex Iron...
This Collaborative Research Structure benefits from translational expertise, from chemistry to the clinic, thanks to its close relationship with the Clinical Investigation Centre - Technological Innovation (CIC-IT) "Ultrasound-Radiopharmaceutical" of the Tours CHRU.
The CERRP has the necessary authorisations from the ANSM ( National Agency for the Safety of Medicines and Health Products), the ASN (Nuclear Safety Authority) and the ARS (Regional Health Agency) for clinical research.
This association of knowledge and production resources is based on the establishment of a cyclotron dedicated to fluorine 18, in the heart of the Touraine urban area.
The CERRP is involved in numerous projects at European and national level: INMIND (Imaging Neuroinflammation in Neurodegenerative Diseases), the Labex Iron...
This Collaborative Research Structure benefits from translational expertise, from chemistry to the clinic, thanks to its close relationship with the Clinical Investigation Centre - Technological Innovation (CIC-IT) "Ultrasound-Radiopharmaceutical" of the Tours CHRU.
The CERRP has the necessary authorisations from the ANSM ( National Agency for the Safety of Medicines and Health Products), the ASN (Nuclear Safety Authority) and the ARS (Regional Health Agency) for clinical research.
Knowledge
- Development of new radiopharmaceuticals to aid in the early diagnosis of cancer and neurodegenerative diseases
- Scintigraphic exploration methods for diagnosis and treatment follow-up
- Small Animal Imaging
Experimental facilities
- Positron Emission Tomography (µPET)
- Cyclotron
- Shielded cells
- Automated radiosynthesis
Applications
- Nuclear medicine
- Oncology
- Cardiology
- Neurology
- Psychiatry
